Merck & Co., Inc: all 2,453 studies
Page 25 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Study of Lonafarnib in Combination With Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer (Study P01901)(TERMINATED)TerminatedNCT00050336Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)CompletedNCT00048607Phase 3
- Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)CompletedNCT00048594Phase 3
- Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)CompletedNCT00044486Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)CompletedNCT00042029Phase 3
- Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED)CompletedNCT00040547Phase 1
- Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED)TerminatedNCT00040534Phase 1
- Safety and Efficacy Study of IL-10 (Tenovil TM) in the Prevention of Post-ERCP Acute Pancreatitis (Study P02580)(TERMINATED)TerminatedNCT00040131Phase 2
- Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry EyeCompletedNCT00037661Phase 3
- Phase III PEG-Intron in HIV-infected Patients (Study P00738)CompletedNCT00035360Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)CompletedNCT00035295Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)CompletedNCT00035282Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)CompletedNCT00035048Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)CompletedNCT00035009Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)CompletedNCT00034983Phase 3
- Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)CompletedNCT00034944Phase 3
- Study of Temozolomide in the Treatment of Brain Metastasis From Non-small-cell Lung Cancer (Study P02143)TerminatedNCT00034697Phase 2
- Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701)CompletedNCT00034684Phase 1/2
- PK/PD Study of Posaconazole for Empiric Treatment of Invasive Fungal Infections in Neutropenic Patients or Treatment of Refractory Invasive Fungal Infections (Study P01893)CompletedNCT00034671Phase 2
- Open Label Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P00041)CompletedNCT00034658Phase 3
- Prophylaxis Trial in High Risk Allogenic Stem Cell Transplant Recipients With Graft vs. Host DiseaseCompletedNCT00034645Phase 3
- Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)CompletedNCT00034632Phase 3
- A Study in Adult and Pediatric Patients With Cystic FibrosisCompletedNCT00034515Phase 1/2
- The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's DiseaseTerminatedNCT00006187Phase 3
- A Study of the Side Effects of L-743,872 in Men With Candidal EsophagitisCompletedNCT00005921Not applicable
- Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With FluconazoleTerminatedNCT00005920Phase 2
- The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention TreatmentStatus unknownNCT00005118Phase 2
- Safety and Effectiveness of PEG-Intron in HIV-Infected PatientsCompletedNCT00005012Phase 2
- Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal CancerTerminatedNCT00003880Phase 2/3
- SCH-58500 in Treating Patients With Primary Ovarian, Fallopian Tube, or Peritoneal Cancer (C95084)CompletedNCT00002960Phase 1
- A Study on the Safety and Effectiveness of L-756423 Plus Indinavir in HIV-Positive Patients Who Have Previously Taken IndinavirCompletedNCT00002452Phase 2
- Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV DrugsStatus unknownNCT00002451Phase 2
- Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive PatientsCompletedNCT00002446Phase 3
- The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002443Not applicable
- A Study to Compare the Effectiveness of Two Anti-HIV Drug CombinationsCompletedNCT00002430Not applicable
- A Study to Compare the Safety and Effectiveness of Indinavir Combined With Stavudine and LamivudineSuspendedNCT00002424Phase 2
- A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected PatientsCompletedNCT00002406Phase 3
- A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive PatientsCompletedNCT00002399Phase 2
- The Safety and Effectiveness of Indinavir Sulfate Plus EfavirenzCompletedNCT00002387Not applicable
- Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With HemophiliaCompletedNCT00002386Phase 4
- The Effectiveness of HIV RNA Viral Load Testing in Determining Treatment Type in HIV-Infected PatientsCompletedNCT00002376Phase 4
- Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected PatientsCompletedNCT00002375Not applicable
- Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease InhibitorsCompletedNCT00002361Phase 2
- A Study of Indinavir Sulfate Given Together With Stavudine to HIV-Positive PatientsCompletedNCT00002354Not applicable
- A Study of L-735,524 in HIV-Positive Children and AdolescentsCompletedNCT00002351Phase 1
- Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice DailyStatus unknownNCT00002241Phase 2
- A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease InhibitorsCompletedNCT00002235Phase 2
- Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With NelfinavirCompletedNCT00002220Phase 3
- A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TCCompletedNCT00002208Phase 3
- The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of InfectionCompletedNCT00002179Phase 4
- A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TCCompletedNCT00002155Not applicable
- Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV RetinitisCompletedNCT00002070Phase 3
- A Pharmacokinetic Study of L-697,661 Alone and in Combination With ZidovudineCompletedNCT00000628Phase 1